InterCure Ltd. (INCR)
NASDAQ: INCR · Real-Time Price · USD
1.460
+0.080 (5.80%)
Apr 23, 2025, 4:00 PM EDT - Market closed
InterCure Employees
InterCure had 270 employees as of December 31, 2023. The number of employees decreased by 100 or -27.03% compared to the previous year.
Employees
270
Change (1Y)
-100
Growth (1Y)
-27.03%
Revenue / Employee
$268,226
Profits / Employee
-$64,553
Market Cap
69.06M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 270 | -100 | -27.03% |
| Dec 31, 2022 | 370 | 20 | 5.71% |
| Dec 31, 2021 | 350 | 275 | 366.67% |
| Dec 31, 2020 | 75 | 0 | - |
| Dec 31, 2019 | 75 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
INCR News
- 2 months ago - InterCure Names Alexander Rabinovich as Chairman Replacing Ehud Barak - PRNewsWire
- 4 months ago - InterCure has Secured Funding of NIS 66M to support the recovery of Nir Oz Facility - PRNewsWire
- 7 months ago - Are Investors Missing The Forest? 35% Stock Drop Masks The International Potential Of This Weed Company - Benzinga
- 8 months ago - InterCure Announces First Half of 2024 Results: Revenue of NIS 126 million and Adjusted EBITDA of NIS 21 million - GlobeNewsWire
- 8 months ago - InterCure Announces Expansion of its Strategic partnership with Cookies to Germany - Business Wire
- 10 months ago - InterCure: A Cannabis Industry Leader Still Flying Under The Radar - Seeking Alpha
- 1 year ago - InterCure to Participate in Canaccord Genuity's 8th Annual Global Cannabis Conference - Business Wire
- 1 year ago - InterCure Announces FY2023 Results: Revenue of NIS 356 million and Adjusted EBITDA of NIS 61 million - Business Wire